Neogen Corporation (NEOG) Q1 2026 Financial Results Summary

0
8

Neogen Corporation (NEOG) Q1 2026 Financial Results Summary

LANSING, Mich., October 9, 2025 – Neogen Corporation (NASDAQ: NEOG) announced today the results of the first quarter ended August 31, 2025. Below is a summary of their financial performance and significant events during the quarter.

Financial and Business Highlights

  • Total Revenue: $209.2 million
  • Decrease: 3.6% compared to $217.0 million in Q1 2025.
  • Core Revenue: Increased by 0.3% after excluding foreign currency effects and impacts from divestitures.

  • Net Income: $36.3 million

  • Earnings per Share: $0.17 per diluted share, compared to a net loss of $12.6 million ($0.06 loss per diluted share) in the prior-year period.
  • This improvement was largely due to a non-cash gain from the sale of the Cleaners and Disinfectants business.

  • Adjusted Net Income: $9.4 million

  • Decrease: 34.7% from $14.4 million in Q1 2025 ($0.04 per diluted share vs. $0.07).

  • Adjusted EBITDA: $35.5 million

  • Adjusted EBITDA Margin: 17.0%, compared to $43.7 million and a margin of 20.1% in Q1 2025.
  • The margin decline was attributed to reduced gross margin and increased operating expenses.

  • Gross Margin: 45.4%

  • Decrease: 3.0 percentage points compared to 48.4% in the same quarter last year.
  • Excluding integration-related costs, gross margin was 49.5%.

Segment Performance

  • Food Safety Segment:
  • Revenue: $152.1 million
  • Decrease: 4.6% compared to $159.3 million in Q1 2025.

    • Core Revenue Decline: 1.7%
    • Impact from divestitures and discontinued products: 3.7%
    • Positive foreign currency impact: 0.8%
  • Animal Safety Segment:

  • Revenue: $57.1 million
  • Decrease: 0.8% compared to $57.6 million in Q1 2025.
    • Core Revenue Increase: 5.8%
    • Negative impact from divestitures: 6.4%
    • Negative foreign currency impact: 0.2%

Corporate Developments

  • Neogen completed the divestiture of its Cleaners & Disinfectants business during the period.
  • The company repaid $100 million in debt using proceeds from the aforementioned divestiture.
  • A new CEO, Mike Nassif, was appointed effective August 11.
  • Restructuring efforts were announced at the end of September to streamline the cost base, which included workforce reductions.

Liquidity and Capital Resources

  • As of August 31, 2025:
  • Cash and Cash Equivalents: $138.9 million
  • Total Outstanding Debt: $800.0 million
  • Committed Borrowing Headroom: $201.5 million

Fiscal 2026 Outlook

  • Neogen is reaffirming its full-year revenue outlook for fiscal year 2026, projecting:
  • Revenue: Between $820 million to $840 million
  • Adjusted EBITDA: Expected in the range of $165 million to $175 million
  • Capital Expenditures: Approximately $50 million

Dividend and Share Repurchase

  • No quarterly dividend has been declared by the company in the reported period.
  • No share repurchase program was mentioned in the report.

This summary encapsulates Neogen Corporation’s Q1 2026 performance amidst challenges while reaffirming their strong market position and future outlook.

For more details, please refer to the company’s investor relations page or tune into their conference call events.

Three months ended August 31, 2025 2024
Revenue $ 152,050 $ 159,345
Animal Safety $ 57,139 $ 57,619
Total revenue $ 209,189 $ 216,964
Cost of revenues $ 114,219 $ 112,038
Gross profit $ 94,970 $ 104,926
Operating expenses
Sales & marketing $ 45,048 $ 45,799
Administrative $ 60,888 $ 51,671
Research & development $ 5,125 $ 5,199
Total operating expenses $ 111,061 $ 102,669
Operating loss (income) $ (16,091) $ 2,257
Interest expense, net $ (15,524) $ (17,622)
Gain on sale of business $ 76,390 $ —
Other, net $ (967) $ (244)
Income (Loss) Before Taxes $ 43,808 $ (15,609)
Income Tax Expense (Benefit) $ 7,470 $ (3,000)
Net Income (Loss) $ 36,338 $ (12,609)
Net Earnings (Loss) Per Diluted Share $ 0.17 $ (0.06)
Shares to calculate per share amount 217,334,926 216,695,348
August 31, 2025 May 31, 2025
Assets
Current Assets
Cash and cash equivalents $ 138,883 $ 129,004
Accounts receivable, net of allowance of $ 138,459 $ 153,384
$5,403 and $5,397
Inventories, net of reserves of $16,865 $ 193,414 $ 190,859
and $16,483
Assets held for sale $ — $ 50,402
Prepaid expenses and other current $ 53,304 $ 53,288
assets
Total Current Assets $ 524,060 $ 576,937
Net Property and Equipment $ 345,893 $ 339,131
Other Assets
Right of use assets $ 16,994 $ 17,152
Goodwill $ 1,065,889 $ 1,064,902
Amortizable intangible assets, net $ 1,389,141 $ 1,410,485
Other non-current assets $ 36,179 $ 35,229
Total Assets $ 3,378,156 $ 3,443,836
Liabilities and Stockholders’ Equity
Current Liabilities
Current portion of debt $ — $ 19,301
Accounts payable $ 76,596 $ 79,605
Accrued compensation $ 20,273 $ 14,134
Income tax payable $ 9,449 $ 5,599
Accrued interest $ 3,556 $ 11,078
Deferred revenue $ 5,824 $ 5,558
Liabilities held for sale $ — $ 6,556
Other current liabilities $ 30,507 $ 32,180
Total Current Liabilities $ 146,205 $ 174,011
Deferred Income Tax Liability $ 277,253 $ 280,907
Non-current debt $ 792,530 $ 874,810
Other non-current liabilities $ 43,519 $ 42,854
Total Liabilities $ 1,259,507 $ 1,372,582
Commitments and Contingencies
Equity
Preferred stock, $1.00 par value, 100,000 shares authorized, none issued $ — $ —
Common stock, $0.16 par value, 315,000,000 shares authorized, $ 34,768 $ 34,728
217,298,626 and 217,044,098 shares issued and outstanding
Additional paid-in capital $ 2,607,452 $ 2,601,848
Accumulated other comprehensive loss $ (23,485) $ (28,898)
Accumulated deficit $ (500,086) $ (536,424)
Total Stockholders’ Equity $ 2,118,649 $ 2,071,254
Total Liabilities and Stockholders’ Equity $ 3,378,156 $ 3,443,836